24/7 Market News Snapshot 12 June, 2025 – ReShape Lifesciences, Inc. Common Stock (NASDAQ:RSLS)
DENVER, Colo., 12 June, 2025 (www.247marketnews.com) – (Nasdaq:RSLS) are discussed in this article.
ReShape Lifesciences, Inc. (Nasdaq:RSLS) is witnessing impressive activity in the stock market, with its shares trading at $2.729 in the pre-market session—a notable 19.17% rise from the previous close of $2.290. The trading volume has surged to 2.80 million shares, reflecting increased investor interest and confidence. This positive momentum may be tied to recent strategic developments within the company, particularly its new partnership aimed at expanding access to healthcare solutions for veterans.
In a significant move, ReShape Lifesciences has entered into an exclusive distribution agreement with Recon Supply, enabling greater access to its innovative medical technologies such as the STIMEL-03 neuromuscular rehabilitation device and the next-generation Lap-Band® 2.0 FLEX for the Veterans Administration (VA) and Department of Defense (DoD) healthcare systems. This partnership will allow ReShape’s state-of-the-art therapeutic solutions to reach over 18 million U.S. veterans and active-duty service members.
Paul F. Hickey, President and CEO of ReShape Lifesciences, emphasized the importance of this agreement, stating it marks a crucial step in their goal to make transformative medical technologies available to those in need. The STIMEL-03 system represents a groundbreaking neurorehabilitation platform integrating real-time EMG biofeedback and personalized electrical stimulation, while the minimally invasive Lap-Band® 2.0 FLEX offers a safe and adjustable approach for combating obesity.
Recon Supply, led by CEO Steve Clark—a U.S. Marine Corps veteran—affirms its alignment with ReShape’s mission to deliver impactful medical solutions to veterans. By harnessing their established connections within VA and DoD facilities, both companies are strategically positioned to enhance the lives of the nation’s heroes through innovative healthcare solutions.
Related news for (RSLS)
- Afternoon Watchlist Builds as Busy Biotech, Blockbuster IPs & Big Institutional Bets Power Late-Day Surge
- MoBot’s Stock Market Highlights – 08/13/25 12:00 PM
- Vyome Announces Nasdaq Approval of Merger with ReShape Lifesciences, Set to Begin Trading as HIND
- 24/7 Market News Snapshot 13 August, 2025 – ReShape Lifesciences, Inc. Common Stock (NASDAQ:RSLS)
- ReShape Lifesciences® Granted U.S. Patent Related to an Intragastric Balloon System